The Enduring Legacy of Ascorbic Acid: A Historical Perspective on Vitamin C

The history of Vitamin C, or ascorbic acid, represents a remarkable journey from an ancient, mysterious affliction to a scientifically understood essential nutrient. This report traces the evolution of human understanding of scurvy, the disease caused by Vitamin C deficiency, from its earliest documented observations to the groundbreaking discoveries that elucidated its cause and led to its widespread availability. The narrative highlights the pivotal role of empirical observation, the advent of systematic scientific inquiry, and the transformative impact of biochemical isolation and industrial synthesis.

The protracted period between the empirical observation that citrus fruits could prevent scurvy and the scientific identification of ascorbic acid underscores the limitations inherent in pre-scientific medical understanding and the formidable challenges involved in isolating specific nutritional factors. While ancient texts like the Ebers Papyrus (1550 BC) and James Lind’s clinical trial (1747) provided early dietary links to scurvy, the definitive isolation of hexuronic acid by Albert Szent-Györgyi in 1928, and its subsequent synthesis by Walter Haworth in 1933, occurred millennia to centuries later.¹ This substantial time lag illustrates that while practical observations were made, the scientific framework and analytical tools required to pinpoint the precise causative agent were absent for a very long time. This distinction between anecdotal observation or empirical remedy and fundamental scientific comprehension highlights the difficulty in establishing causality without controlled experimentation and advanced biochemical analysis.

The historical trajectory of Vitamin C serves as a compelling illustration of the evolution of modern medicine and nutritional science. It demonstrates the transition from relying on anecdotal remedies to embracing evidence-based practice, and from merely treating disease symptoms to understanding fundamental biological processes and preventing deficiencies through comprehensive public health measures. This progression is further exemplified by the initial skepticism and slow adoption that often accompany scientific breakthroughs, even when the supporting evidence is compelling. The journey begins with ancient descriptions of scurvy and rudimentary treatments like onions or tree bark.¹ It then advances to James Lind’s pioneering controlled trial, a foundational step in evidence-based medicine.² Despite its rigor, widespread implementation of Lind’s findings was delayed.¹⁰ The eventual isolation and synthesis of Vitamin C transformed it from an enigmatic “antiscorbutic factor” into a precisely defined chemical compound.¹ This scientific advancement enabled its industrial production and widespread application in food fortification.³ This comprehensive historical arc powerfully demonstrates the progression of the scientific method: from initial observation to hypothesis formulation, rigorous experimentation, molecular characterization, industrial application, broad public health initiatives, and finally, ongoing research into its wider physiological roles and therapeutic potential.

Introduction: Scurvy’s Ancient Scourge and Early Observations

Scurvy, a nutritional deficiency stemming from inadequate Vitamin C levels, has been a documented affliction since antiquity, impacting numerous organ systems due to Vitamin C’s critical involvement in connective tissue synthesis.¹ The earliest known accounts of this debilitating disease can be found in the Ebers Papyrus, an Egyptian medical scroll from approximately 1550 BC. This ancient text described the condition among soldiers and sailors, populations with limited access to fresh fruits and vegetables, thereby establishing an early, albeit unarticulated, link to diet.¹ Ancient Greek and Roman literature further elaborated on the clinical signs and symptoms of scurvy. Hippocrates of Cos, the revered “father” of Western medicine, provided vivid descriptions around 400 BC, noting symptoms such as “foetid breath, lax gums and haemorrhage from the nose”.² Common manifestations observed historically included gingival bleeding, joint pain (arthralgias), skin discoloration, impaired wound healing, perifollicular hemorrhage, and ecchymoses.¹ If left untreated, the progression of the deficiency led to more severe symptoms, including anemia, swollen and purple gums, loosened teeth, subcutaneous bleeding appearing as a “scurvy rash,” easily bruised and rough, scaly skin, swollen legs, the reopening of previously healed wounds, and characteristic dry, brittle hair that coiled like a corkscrew.¹⁸

Scurvy held profound historical significance, afflicting human populations for centuries. It notably decimated European and British explorers during the Renaissance.¹ The disease was a significant contributor to sickness and mortality during major historical periods, including the Great Potato Famine, the American Civil War, expeditions to the North Pole, and the California Gold Rush.¹ During the Age of Exploration, commencing in the mid-15th century, scurvy emerged as a primary cause of disability and death among European sailors.¹² Estimates suggest that up to 50% of sailors on major voyages succumbed to scurvy, with the disease claiming the lives of as many as two million sailors between 1500 and 1800.¹⁹ The prolonged absence of fresh fruits and vegetables in the diets of sailors and soldiers, who often spent months at sea, rendered them particularly vulnerable to this severe nutritional deficiency.¹⁴

Despite early recognition of scurvy, knowledge of effective treatments and its dietary origins was repeatedly lost and rediscovered well into the early 20th century.²¹ A notable instance occurred in 1535 when French explorer Jacques Cartier’s ship became stranded on the frozen St. Lawrence River, leading to a scurvy outbreak among his crew. Native Americans offered a remedy: a tea derived from the bark of a local tree, likely white cedar, which proved effective.² Regrettably, this crucial knowledge was not widely disseminated.¹⁰ Similarly, in 1593, the crew of Sir Richard Hawkins’ British ship found that consuming oranges and lemons in Brazil cured their condition. However, Hawkins mistakenly attributed scurvy to unsanitary ship conditions, causing this vital observation to be overlooked.¹⁴ Concurrently, French negotiator Francois Pyrard documented his crew’s recovery after consuming citrus, but this observation was also dismissed due to the prevailing belief that the disease was contagious.¹⁴

During the 17th century, common “cures” for scurvy included daily doses of vinegar, elixir of vitriol (sulfuric acid mixed with alcohol), and potent patent medicines like Ward’s Drop and Pill, which acted as strong purgatives and diuretics.¹⁰ These remedies were largely ineffective against clinically defined scurvy.¹¹ While Sir James Lancaster carried lemon juice on his 1601 voyage to the Spice Islands, this practice was not widespread due to the expense of re-stocking.¹⁰ John Woodall, surgeon general of the East India Company, prescribed lemon juice as a daily preventative in his 1617 work, The Surgeon’s Mate. Yet, by the 1630s, the East India Company favored tamarinds and oil of vitriol, deeming preventative measures too costly if the illness had not yet manifested.¹⁰ Woodall later recommended fresh plants and berries such as scurvy grass, gooseberries, turnips, radishes, and nettles, which, when fresh, were good sources of ascorbic acid. However, their efficacy was significantly diminished or lost when dried for extended voyages.¹⁰

The persistent re-discovery and subsequent forgetting or misattribution of effective scurvy treatments highlights a critical limitation in pre-scientific medical knowledge: the absence of systematic documentation, widespread dissemination, and, crucially, a robust theoretical framework—such as germ theory or nutritional deficiency theory—to explain why a treatment worked. Without this fundamental understanding, effective empirical remedies remained isolated anecdotes or were dismissed, preventing sustained public health impact. The historical record explicitly indicates that knowledge of scurvy cures was “repeatedly forgotten and rediscovered” over centuries.¹⁴ For example, despite observing citrus curing scurvy, both Sir Richard Hawkins and Francois Pyrard attributed the disease to “unsanitary conditions” or believed it was “very contagious”.¹⁴ This demonstrates that even when empirical evidence was present, the dominant medical paradigms of the time, such as the miasma theory or the “contagious disease paradigm,” often superseded practical observation. The lack of a rigorous scientific method for validating and disseminating knowledge meant that effective remedies remained isolated observations rather than integrated medical practice, allowing the disease to persist for millennia.

The historical struggle with scurvy profoundly underscores the devastating impact of dietary deficiencies on human populations, particularly in contexts of limited food diversity, such as long sea voyages or famines. It also reveals the significant societal cost—manifested in high mortality rates, widespread disability, and impaired exploration and military efforts—resulting from a lack of fundamental nutritional understanding. This set the stage for the eventual scientific breakthroughs that would transform public health. Scurvy “decimated” explorers and was a “significant source of sickness and mortality” during major historical events.¹ It was the “leading cause of naval deaths” between the 16th and 18th centuries, claiming more lives than all battles and storms combined ²⁰, and was presumed to kill 50% of sailors on extended voyages.²¹ This was not merely a health problem; it was a geopolitical and economic impediment that severely limited exploration, trade, and military power. The fact that such a widespread and deadly disease was caused by a simple dietary lack, yet remained a scourge for millennia, highlights the primitive state of nutritional science and public health infrastructure until later scientific discoveries provided the necessary insights and tools. The sheer scale of its impact provided a powerful impetus for future scientific inquiry into its cause and prevention.

The Dawn of Scientific Inquiry: James Lind’s Pioneering Clinical Trial

By the mid-18th century, scurvy had debilitated hundreds of thousands of British sailors, posing a significant health crisis for naval forces worldwide. The disease caused debilitating symptoms and frequently led to death, severely hampering maritime operations.⁵

In this critical context, James Lind, a Scottish naval surgeon, conducted a seminal experiment in 1747 while serving aboard the HMS Salisbury.² This methodical approach is widely recognized as the first clinical trial in medical history, laying a foundational stone for evidence-based medicine.¹³ Lind carefully selected 12 sailors, all exhibiting symptoms of scurvy, and divided them into six pairs.¹⁰ To ensure a controlled environment, all participants were housed in a contained, damp area and maintained on the same standard basic diet.¹⁰ Each pair was then assigned a different daily treatment, representing various common or proposed remedies of the era:

• One quart of cider ¹⁰
• 25 drops of elixir of vitriol (a mixture of alcohol and sulfuric acid) three times daily ¹⁰
• Two spoonfuls of vinegar three times daily ¹⁰
• A small paste made of garlic, mustard seed, horseradish, balsam of Peru, and gum myrrh ¹²
• A nutmeg-sized amount of “electuary” (medicinal paste) three times daily ¹⁰
• A half-pint of sea water daily ¹⁰
• Two oranges and one lemon daily for six days, until the ship’s limited supply was exhausted ¹⁰

Lind meticulously observed and recorded the effects of these treatments over the six-day period.¹³ The results were striking: the pair who consumed oranges and lemons demonstrated significant and rapid improvement within just a few days.² Their recovery was sufficient to enable them to assist in nursing the other sick men.¹⁰ While the group receiving cider also showed some improvement, they remained notably weaker.¹⁰ Lind’s experiment provided the “first scientific evidence of the effectiveness of citrus fruits in curing scurvy”.¹³ He subsequently published his detailed experiments and findings in “A Treatise of the Scurvy” in 1753.¹

Table 1: James Lind’s Scurvy Experiment Design and Outcomes (1747)

Treatment Group	Number of Sailors	Observed Outcome/Recovery	Source
1 quart cider	2	Some improvement but remained weak	10
25 drops elixir of vitriol (3x daily)	2	No significant improvement	10
2 spoonfuls vinegar (3x daily)	2	No significant improvement	10
Garlic, Mustard, Horseradish paste	2	No significant improvement	12
Sea water (half pint daily)	2	No significant improvement	10
2 oranges and 1 lemon daily	2	Rapid and significant recovery	2

Despite the groundbreaking significance of Lind’s work, its full acceptance and implementation by the medical community and, critically, the British Navy, took several decades.⁵ This delay was primarily due to the prevailing “eminence-based” medical practice, which often prioritized the pronouncements of established authorities over empirical evidence.²³ Furthermore, the lack of understanding of the specific causative agent (Vitamin C itself) and the logistical challenges and costs associated with providing fresh produce or stable citrus extracts on long voyages contributed to the slow adoption.¹⁰ The persistent adherence to the “contagious disease paradigm” also played a role, as evidenced by Captain James Cook’s continued emphasis on hygiene and fresh air, even as he successfully used fresh vegetables to prevent scurvy.¹⁴ This demonstrates the inertia of entrenched beliefs and the critical need for persistent advocacy even after a compelling scientific demonstration. The absence of knowledge about the specific molecule in citrus that conferred the benefit made it challenging to standardize treatment and build complete trust in the remedy.

Captain James Cook, beginning his voyages in 1768, successfully prevented scurvy among his crew by enforcing “fresh air, cleanliness, and an antiscorbutic diet,” ensuring stops for fresh vegetables and water whenever possible.¹ His provisions included items like “barrels of malt, sauerkraut, marmalade of carrots, mustard, portable soup, distilled water, and a small quantity of rob of lemon and oranges”.¹⁰ Although Cook did not fully comprehend which specific intervention had the greatest impact, his methods significantly improved his sailors’ quality of life.¹⁰ Notably, Cook still adhered to the prevailing “contagious disease paradigm,” which somewhat obscured the true cause of scurvy for him.¹⁴

Gilbert Blane, personal physician to Admiral Rodney, emerged as a key advocate for Lind’s findings. In 1780, he actively campaigned to persuade the Royal Admiralty to issue daily lemon juice rations to all sailors.¹⁰ Blane compiled his recommendations, drawing from Lind’s Treatise and Cook’s journey documents, in “A Short Account of the Most Effectual Means of Preserving the Health of Seamen,” advocating for ideal conditions of cleanliness and daily allowances of lemon juice.¹⁰ It was finally in 1795 that Blane successfully convinced the Royal Admiralty to mandate a daily allowance of lemon juice for sailors.² This practice led to British sailors being colloquially known as “limeys”.² However, even after official adoption, the effectiveness of the lemon juice rations was sometimes inconsistent due to variations in preparation methods, such as exposure to heat or copper pipes, or substitution with less potent lime juice, which could lead to a resurgence of the disease.²

The story of Lind and Blane illustrates the crucial interplay between scientific discovery, dedicated advocacy, and the eventual translation into public health policy. A single scientific breakthrough, no matter how profound, often requires sustained effort from committed individuals to overcome inertia, challenge entrenched beliefs, and navigate logistical complexities to achieve systemic change. Lind’s experiment was a “pioneering work” and “groundbreaking” ¹³, establishing a model for evidence-based medicine. However, it was Gilbert Blane who actively “attempted to persuade the Royal Admiralty” and ultimately “finally convince[d] the Royal Admiralty to require a daily allowance of lemon juice”.¹⁰ This demonstrates that scientific findings alone are frequently insufficient; dedicated advocacy and effective policy influence are necessary to drive widespread implementation and realize significant public health benefits. The explicit mention of Lind’s “methodical approach to testing treatments laid the foundation for modern clinical trials” and his emphasis on “control groups and systematic observation” ¹² positions this historical event as a foundational moment in the development of modern medical research methodology, showcasing how early scientific rigor, even with limitations, can pave the way for future advancements.

Isolation, Identification, and Synthesis: Unraveling Ascorbic Acid

Even before its definitive discovery in 1932, nutrition experts had recognized that an unidentified substance in citrus fruits possessed the ability to prevent scurvy.¹⁹ A significant advancement in the quest for this elusive factor occurred in 1907 when Norwegian biochemists Axel Holst and Alfred Fröhlich demonstrated that a scurvy-like condition could be reliably induced in guinea pigs by restricting certain foods.² Guinea pigs, like humans, are among the few species that lack the enzyme necessary to synthesize their own Vitamin C.³ When these guinea pigs were subsequently fed cabbage, their symptoms disappeared, initiating an intensive international search for the specific nutrient responsible for this antiscorbutic effect.²

Albert Szent-Györgyi, a Hungarian biochemist, played a pivotal role in this scientific pursuit.¹ In 1928, he successfully isolated an organic reducing agent from various plant juices and animal tissues, which he initially named “hexuronic acid”.² His initial extraction was from the adrenal cortices of oxen, and he later isolated it from sources such as cabbage, oranges, and paprika.¹ Szent-Györgyi’s research interest was initially sparked by studying the “browning” process in plants. He observed that this browning was caused by oxidation and could be inhibited by the addition of citrus juice. This led him to focus on isolating the specific agent in citrus juice responsible for counteracting this oxidation.⁵ For two years after its isolation, Szent-Györgyi actively sought an abundant source of hexuronic acid, as he suspected it was the elusive Vitamin C, the antiscorbutic factor identified by Holst and Fröhlich.⁵ In 1932, working with J.L. Svirbely, and concurrently with Charles Glen King, Szent-Györgyi definitively proved that hexuronic acid was indeed the antiscorbutic factor by demonstrating its ability to prevent and cure scurvy in guinea pigs.¹ A widely recounted anecdote describes Szent-Györgyi’s serendipitous discovery of paprika as an exceptionally abundant source of hexuronic acid; he allegedly tested it after his wife served it for dinner, seeking to avoid eating it.⁵

Following Szent-Györgyi’s isolation, British chemist Walter Haworth determined the precise molecular structure of hexuronic acid in 1932.² In recognition of its potent antiscorbutic (anti-scurvy) properties, Haworth and Szent-Györgyi collaboratively proposed renaming the compound “ascorbic acid”.² In 1933, Haworth led a team of scientists, including R.G. Ault and Edmund Hirst, that successfully achieved the first chemical synthesis of ascorbic acid.² This landmark achievement marked the first time any vitamin had been chemically synthesized.⁶ The D-enantiomer of ascorbic acid was also synthesized, but it does not occur naturally and has no known biological role.⁸

The parallel and sometimes competitive efforts to isolate and identify Vitamin C, involving Szent-Györgyi, King, and Haworth, highlight the intense scientific “race” of the early 20th century. This race was driven by the recognition of a significant biological effect—the antiscorbutic factor—before its precise chemical identity was known. The subsequent rapid determination of its structure and chemical synthesis, occurring within five years of its isolation, demonstrates the accelerating pace of biochemical and organic chemistry research during that period. The timeline from Holst and Fröhlich’s biological observation in 1907 to Szent-Györgyi’s isolation of hexuronic acid in 1928, and then to Haworth’s structural determination in 1932 and synthesis in 1933, reveals a remarkably swift progression.² This rapid acceleration stands in stark contrast to the millennia it took for humanity to empirically link citrus to scurvy and underscores the transformative power of modern scientific methodology and technological advancements in the early 20th century.

In 1937, Albert Szent-Györgyi was awarded the Nobel Prize in Physiology or Medicine for his discoveries concerning biological combustion, including his pivotal role in the discovery of Vitamin C.² Walter Haworth shared the Nobel Prize in Chemistry in the same year for his groundbreaking investigations on carbohydrates and his structural determination and synthesis of Vitamin C.²

The isolation and synthesis of Vitamin C marked a fundamental paradigm shift from merely treating symptoms with empirical remedies to understanding and addressing the root cause of a deficiency at a molecular level. This breakthrough not only provided a definitive cure for scurvy but also paved the way for the broader field of vitamin research and the industrial production of essential nutrients, fundamentally transforming public health on a global scale. Prior to 1928, scurvy was treated with citrus fruits, but the underlying mechanism of action remained a mystery. The isolation of hexuronic acid and its subsequent definitive identification as the “antiscorbutic factor” provided the crucial chemical explanation.⁵ The successful chemical synthesis of ascorbic acid meant that human reliance on natural sources was no longer necessary, opening the door to mass production and widespread fortification.⁶ This represents a profound shift from empirical, observational medicine to molecular, mechanistic medicine, allowing for precise intervention and prevention rather than just symptomatic treatment. This foundational work also laid the groundwork for the discovery and understanding of other essential vitamins and the diseases caused by their deficiencies.

The Industrial Era: Widespread Availability and Impact

The scientific breakthroughs in Vitamin C synthesis rapidly translated into industrial production, dramatically influencing global public health. The first chemical synthesis of L- and D-ascorbic acid was reported in 1933 by R.G. Ault, Walter Haworth, and their colleagues.⁹ In the same year, Polish chemist Tadeusz Reichstein and his team at ETH Zürich developed the “Reichstein process,” a robust chemical/microbial method for producing ascorbic acid from D-glucose.⁸ This multi-step process involved several key reactions: hydrogenation of glucose to sorbitol, enzymatic oxidation of sorbitol to sorbose, protection of hydroxyl groups with acetone, further oxidation to carboxylic acid, and finally, acid-catalyzed hydrolysis and lactonization to yield ascorbic acid.⁸ The Reichstein process served as the predominant manufacturing route for ascorbic acid until the 1960s.⁹

The Reichstein process was largely superseded by a more efficient two-step fermentation process, initially developed in China in the 1960s and further advanced in the 1990s.⁸ This modern biotechnological method streamlines production by bypassing the need for acetone-protecting groups. In this process, a second genetically modified microbe species, such as mutant Erwinia, oxidizes sorbose into 2-ketogluconic acid (2-KGA), which then undergoes ring-closing lactonization via dehydration to produce ascorbic acid.⁸ This biotechnological method is now the predominant process used by the ascorbic acid industry in China, which currently supplies approximately 70% of the world’s ascorbic acid.⁸

Although scurvy was historically a widespread and devastating disease, particularly among sailors, its prevalence has dramatically reduced in modern times. This reduction is primarily attributable to widespread Vitamin C supplementation and increased dietary intake.¹ The commencement of industrial production of Vitamin C in the early 1930s made the essential nutrient widely available and affordable.²⁴ While sporadic cases of scurvy still occur, particularly in underdeveloped regions, among at-risk populations, or in individuals with poor dietary habits (e.g., chronic alcohol users, those with mental disorders, or individuals on highly restrictive diets), it is now rare in developed countries compared to other nutritional deficiencies.¹ A significant public health measure demonstrating this impact is the addition of Vitamin C to virtually all commercially available baby formulas, which effectively prevents infantile scurvy.²¹

The rapid development of industrial synthesis methods for Vitamin C, evolving from the Reichstein process to modern fermentation techniques, demonstrates the direct and immediate application of biochemical breakthroughs to large-scale public health solutions. This transition from laboratory isolation to industrial production was instrumental in transforming Vitamin C from a scientific curiosity into a widely accessible public health tool, thereby enabling the near-eradication of scurvy in developed nations. The timeline from Haworth’s chemical synthesis in 1933 to the development of the Reichstein process in the same year, and subsequently the more advanced Chinese two-step fermentation process by the 1960s, illustrates a very rapid scaling of production capabilities.⁶ This industrial capacity allowed Vitamin C to move beyond a niche medical treatment to a ubiquitous food additive and supplement ⁴, making it accessible enough to effectively eliminate a disease that had plagued humanity for millennia.¹ This represents a clear cause-and-effect relationship: scientific synthesis capability directly leading to industrial production, which in turn leads to a profound public health impact.

The industrial fortification of foods began nearly a century ago, in the early 20th century, as a strategic public health measure to address diseases and disorders resulting from inadequate intake of specific micronutrients within the population’s food base.¹⁶ With the advent of industrial-scale synthesis of various vitamin and mineral compounds in the 1930s and 1940s, widespread fortification of foods became both technically feasible and economically viable.¹⁶ Vitamin C is now omnipresent in the food industry, frequently listed as additive E300, owing to its valuable antioxidant and acidifying properties.⁴ Food fortification serves multiple purposes: it can restore nutrients lost during food processing (a process also known as enrichment) or standardize the nutrient content that naturally varies in food products (e.g., adding Vitamin C to orange juice to compensate for seasonal and processing variations).¹⁶ Fortified foods, including breakfast cereals (such as Kellogg’s ‘Pep’, first fortified with B vitamins and Vitamin D in 1938), contribute significantly to micronutrient intakes in developed countries.¹⁷ This widespread availability of synthetic Vitamin C and its strategic use in food fortification have been critical factors in the near-eradication of scurvy in many parts of the world.¹

The success of Vitamin C supplementation and food fortification in preventing scurvy provides a compelling historical precedent and model for addressing other micronutrient deficiencies through broad public health interventions. It powerfully illustrates how scientific and industrial advancements, when applied strategically and at scale, can fundamentally alter the landscape of global health, shifting the focus from merely treating diseases to widespread prevention through nutritional means. The “dramatic reduction in the prevalence of scurvy in modern times owing to vitamin C supplementation and intake” ¹ and the fact that “virtually all commercially available baby formulas contain added vitamin C, preventing infantile scurvy” ²¹ clearly demonstrate a highly successful public health model. This success with Vitamin C set a crucial precedent and provided a blueprint for fortifying other widely consumed foods with other essential nutrients (e.g., iodine in salt, folic acid in flour) ¹⁶, thereby becoming a cornerstone of modern nutritional policy. This is a broader implication for how nutritional science and industrial capabilities have synergistically shaped public health strategies, moving beyond individual treatment to population-level prevention.

Beyond Scurvy: The Expanding Physiological Roles of Vitamin C

Beyond its well-known role in preventing scurvy, Vitamin C plays multifaceted physiological functions, highlighting its importance as a ubiquitous enzymatic cofactor and a potent antioxidant.

Vitamin C is a crucial nutrient responsible for the proper development, growth, and healing of skin, bones, and connective tissue throughout the body.¹⁸ It plays a well-established role in collagen synthesis and, consequently, scurvy prevention.²⁶ The molecular mechanism underlying scurvy involves a reduced function of prolyl hydroxylase, an enzyme vital for collagen formation. This reduction leads to the production of collagen polypeptides that lack hydroxyproline, resulting in unstable triple-helical collagen molecules essential for tissue integrity.²⁶ As a vital cofactor for three groups of enzymes—prolyl-3-hydroxylases, prolyl-4-hydroxylases, and lysyl hydroxylases—Vitamin C is directly involved in collagen biosynthesis through the hydroxylation of proline and lysine residues of procollagen polypeptides.²⁶ This hydroxylation is critical for collagen’s extracellular stability and its ability to support the epidermis.²⁷ Vitamin C’s specific role is to maintain the iron cofactor at the active sites of these hydroxylases in a reduced (Fe2+) state, thereby enabling them to sustain their enzymatic activity and facilitate the formation of stable triple-helical collagen.²⁶ A minimum of 35% of the prolyl residues must be hydroxylated to stabilize the tertiary structure of collagen at normal physiological temperatures.²⁶ The classic symptoms of scurvy, such as bleeding gums, skin hemorrhages, and impaired wound healing, are direct consequences of weakened collagen structures and fragile capillaries due to Vitamin C deficiency.¹

Vitamin C is also a powerful antioxidant, protecting cells against damage from free radicals. These unstable molecules are produced as byproducts of normal cellular activity and can cause cumulative damage over a lifetime.¹⁸ It helps neutralize various reactive oxygen species (ROS) and reactive nitrogen species (RNS), which, in excess, can be highly toxic to cells.²⁶ As the primary water-soluble antioxidant in the body, Vitamin C safeguards cell membranes, DNA, cellular proteins, and lipids from the oxidizing effects of these free radicals.²⁶ It participates in complex antioxidant systems and plays a crucial role in the non-enzymatic regeneration of other antioxidant molecules, such as alpha-tocopherol (Vitamin E), by re-converting its oxidized forms back to their active state.²⁶ While generally acting as an antioxidant, it is important to note that excessive Vitamin C intake can paradoxically lead to increased oxidative stress by participating in Fenton reactions. However, this pro-oxidant effect is typically observed at very high doses and is not a concern for most individuals under normal circumstances.¹⁹

The diverse array of Vitamin C’s physiological roles, extending far beyond its well-known function in scurvy prevention, reveals its fundamental importance as a ubiquitous enzymatic cofactor and potent antioxidant. This suggests that even subclinical deficiencies, not severe enough to cause overt scurvy, could subtly impair numerous metabolic pathways, potentially contributing to a range of chronic health issues, such as cardiovascular diseases, cognitive decline, and even certain cancers.²⁶ The extensive details provided on Vitamin C’s roles in collagen synthesis, carnitine synthesis, catecholamine synthesis, peptide amidation, tyrosine metabolism, gene transcription, and epigenetic regulation, in addition to its antioxidant function and role in iron absorption, illustrate its pervasive involvement in human physiology.¹⁸ The sheer number and variety of these functions indicate that Vitamin C is not merely an “anti-scurvy” agent but a critical component for the proper functioning of a vast network of biological processes. Therefore, even mild or chronic deficiencies could have widespread, subtle, and potentially long-term negative consequences across multiple organ systems, contributing to a broader spectrum of health challenges beyond the acute symptoms of scurvy.

Beyond collagen synthesis and antioxidant activity, Vitamin C serves numerous other enzymatic cofactor roles:

• Carnitine Synthesis: It is an important cofactor for the activity of two enzymes, 6-N-trimethyllysine dioxygenase and gamma-butyrobetaine dioxygenase, both integral to the carnitine biosynthetic pathway. Carnitine is essential for transporting long-chain fatty acids into mitochondria for ATP production via beta-oxidation.²⁶
• Catecholamine Norepinephrine Synthesis: High concentrations of Vitamin C are found in brain and neuroendocrine tissues, such as the adrenal glands. It acts as a cofactor in the biosynthesis of norepinephrine, specifically in a step mediated by tyrosine hydroxylase, and in the conversion of dopamine to norepinephrine by dopamine beta-hydroxylase.²⁶
• Peptide Amidation: Vitamin C is a cofactor for peptidylglycine alpha-amidating mono-oxygenase, an enzyme that catalyzes the final and essential step of amidation of the terminal carboxyl in the biosynthesis of various neuropeptides and peptide hormones.²⁶
• Tyrosine Metabolism: It functions as a cofactor of 4-hydroxyphenylpyruvate dioxygenase, an enzyme involved in tyrosine catabolism, catalyzing the conversion of 4-hydroxyphenylpyruvate to homogentisate. The final products of tyrosine degradation, fumarate and acetyl coenzyme A, are important for energy production.²⁶
• Iron Absorption: Vitamin C significantly enhances the absorption of non-heme iron (the type found in plant foods) in the intestine. It achieves this by reducing ferric iron (Fe3+) to the more readily absorbed ferrous state (Fe2+).¹⁸
• Immune Regulation: Vitamin C stimulates phagocytosis and antibody formation, contributing to immune system function.²⁸ Some research also suggests it might modulate nitric oxide production and possess antiviral properties.³¹
• Gene Transcription & Epigenetic Regulation: Beyond its direct role in collagen synthesis, Vitamin C acts as an enzymatic cofactor in upregulating and stabilizing transcripts of collagen genes (types I and III) in the skin. It also assists other prolyl hydroxylases in the hydroxylation of hypoxia-inducible factor 1α (HIF-1α), a critical transcription factor for cellular response to low-oxygen conditions. Furthermore, it plays a role in DNA and histone demethylation processes via ten-eleven translocation (TET) enzymes.²⁶
• Other Roles: Vitamin C is also essential for the synthesis of serotonin, helps stimulate the initial step in cholesterol metabolism to bile acids, and reduces methemoglobin back to hemoglobin.²⁸

The expanding understanding of Vitamin C’s physiological mechanisms highlights the complexity of nutritional science and the ongoing discovery of how seemingly simple nutrients exert profound effects on health. The continuous identification of new roles, from basic metabolic pathways to intricate epigenetic regulation, demonstrates that the scientific journey of Vitamin C is far from complete. This evolving knowledge necessitates a dynamic approach to nutritional recommendations and underscores the potential for future therapeutic applications.

Contemporary Debates and Future Directions: RDA, Megadosing, and Emerging Research

The understanding of Vitamin C’s optimal intake has evolved significantly over time, leading to the establishment of Recommended Dietary Allowances (RDAs) and Tolerable Upper Intake Levels (ULs) by various national and international health organizations. For adults aged 19 years and older, the current RDA is generally 90 mg daily for men and 75 mg for women in the United States and Canada.¹ These recommendations are based on Vitamin C’s physiological and antioxidant functions in white blood cells and are set higher than the minimum amount required to prevent overt deficiency.³² Specific recommendations are also provided for other demographic groups: pregnant individuals require 85 mg daily, lactating individuals 120 mg daily, and smokers an additional 35 mg per day due to depleted Vitamin C levels caused by smoking.¹⁹ For children, RDAs vary by age, ranging from 15 mg for ages 1-3 years to 75 mg for boys aged 14-18 years and 65 mg for girls in the same age group.³ The Tolerable Upper Intake Level (UL) for adults is set at 2,000 mg daily, as intakes above this amount may cause gastrointestinal distress and diarrhea.¹ Absorption of Vitamin C decreases significantly, to less than 50%, at doses exceeding 1,000 mg per day, as the body tightly controls plasma and tissue concentrations.¹⁹ Historically, the U.S. RDAs were first developed during World War II and have been regularly revised to reflect the latest scientific information, with significant updates occurring in 2000 and 2016.³

A notable controversy surrounding Vitamin C emerged in the 1970s with Linus Pauling, a two-time Nobel laureate, who became a prominent advocate for consuming large doses of Vitamin C to prevent and treat the common cold.² Pauling’s book, “Vitamin C and the Common Cold,” published in 1970, became a bestseller and significantly influenced public perception.² He asserted that daily megadoses (equivalent to the amount in 12 to 24 oranges) could prevent colds and some chronic diseases.¹⁹ However, Pauling’s recommendations were met with substantial criticism from the medical community, who pointed to a lack of robust experimental support and accused him of overstepping his expertise as a biochemist rather than a physician.²³ Critics labeled his approach as “eminence-based” science, contrasting it with the “evidence-based” science that relies on randomized, placebo-controlled trials.²³ Despite the criticism, Pauling’s advocacy spurred continued scientific inquiry into Vitamin C’s broader implications.³¹ Reviews of subsequent studies indicate that while megadoses (greater than 500 mg daily) generally have no significant effect on the common cold for healthy individuals, they may provide a moderate benefit in decreasing the duration and severity of colds in some specific groups.¹⁹

The tension between scientific consensus and public perception, as exemplified by the Linus Pauling controversy, highlights the challenges in communicating complex nutritional science. Pauling’s immense scientific reputation allowed his claims to gain widespread public traction despite insufficient rigorous evidence at the time.²³ This situation demonstrates how public health messaging can be influenced by charismatic figures, even when the scientific community remains cautious or critical. It underscores the importance of clear, evidence-based communication to distinguish between established scientific findings and speculative claims, particularly when dealing with widely available supplements.

Beyond the common cold, emerging research continues to explore the potential therapeutic applications of Vitamin C. Pauling himself proposed high-dose Vitamin C as an adjunct therapy for cancer, claiming it could improve the general health and survival time of cancer patients.³¹ Recent studies have provided some support for this idea, showing that Vitamin C can selectively kill cancer cells through mechanisms involving reactive oxygen species, though the exact molecular targets and selective nature of this effect are still under investigation.³¹ Research also investigates Vitamin C’s potential in cardiovascular diseases, including hypertension, atherosclerosis, and coagulation abnormalities, though findings regarding its association with coronary heart disease risk remain controversial.²⁹ Its high concentrations in the brain suggest a neuroprotective role, with studies exploring its involvement in catecholamine synthesis and potential benefits in cognitive activity for conditions like schizophrenia and Alzheimer’s disease.²⁹ Furthermore, Vitamin C’s role in skin health is being actively studied. Topical application of ascorbic acid can penetrate the epidermis into dermal layers, reducing UV-related DNA damage, limiting pro-inflammatory cytokines, and protecting against apoptosis.²⁷ It also regulates collagen synthesis, increasing collagen protein synthesis for damaged skin repair and reducing wrinkling.²⁷ Oral supplementation, particularly in combination with Vitamin E, has shown some promise in increasing photoprotection from UV light.²⁷

The dynamic nature of nutritional science is evident in the ongoing evolution of Vitamin C recommendations and the continuous exploration of its therapeutic potential. Balancing established dietary guidelines, which are based on preventing deficiency and supporting fundamental physiological functions, with the results of new research into higher doses and broader applications is a complex task. The scientific community is constantly refining its understanding of optimal nutrient intake and the nuanced roles of compounds like Vitamin C in health and disease. This ongoing research underscores that while Vitamin C’s essential role in preventing scurvy is well-established, its full spectrum of benefits and optimal applications in various health contexts are still being elucidated.

Conclusion

The history of Vitamin C is a compelling narrative of scientific progress, transforming a devastating ancient disease into a largely preventable condition. From early empirical observations of scurvy in ancient civilizations to James Lind’s pioneering clinical trial, the journey highlights humanity’s persistent struggle to understand and combat dietary deficiencies. The eventual isolation of hexuronic acid by Albert Szent-Györgyi and its chemical synthesis by Walter Haworth marked a pivotal paradigm shift, moving from symptomatic treatment to a molecular understanding of disease.

The industrial production of ascorbic acid revolutionized public health, leading to the near-eradication of scurvy in developed nations through widespread supplementation and food fortification. This success serves as a powerful testament to the impact of scientific and industrial advancements when applied strategically to public health challenges. Beyond its role in scurvy prevention, Vitamin C has been revealed as a multifaceted essential nutrient, crucial for collagen synthesis, acting as a potent antioxidant, and serving as a vital cofactor in numerous enzymatic reactions critical for metabolism, neurological function, and immune regulation.

Contemporary research continues to explore the broader therapeutic potential of Vitamin C, from its debated role in common cold prevention to its emerging applications in cancer therapy, cardiovascular health, neurodegenerative diseases, and skin protection. This ongoing inquiry underscores the dynamic nature of nutritional science, where established guidelines are continually refined by new discoveries. The story of Vitamin C is a testament to the enduring human quest for scientific understanding and its profound capacity to improve global health and well-being.

Works cited

1. Scurvy: Rediscovering a Forgotten Disease – PMC, accessed June 4, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10296835/
2. Vitamin C history – timeline – Science Learning Hub, accessed June 4, 2025, https://www.sciencelearn.org.nz/resources/1690-vitamin-c-history-timeline
3. Vitamin C – Wikipedia, accessed June 4, 2025, https://en.wikipedia.org/wiki/Vitamin_C
4. The 4 major dates in the history of vitamin C – Novoma, accessed June 4, 2025, https://novoma.com/en/blogs/articles/4-dates-majeures-de-l-histoire-de-la-vitamine-c
5. Albert Szent-Györgyi | Science History Institute, accessed June 4, 2025, https://www.sciencehistory.org/education/scientific-biographies/albert-szent-gyorgyi/
6. Sir (Walter) Norman Haworth – MSU Chemistry, accessed June 4, 2025, https://www.chemistry.msu.edu/faculty-research/portraits/haworth-norman.aspx
7. Norman Haworth – Wikipedia, accessed June 4, 2025, https://en.wikipedia.org/wiki/Norman_Haworth
8. Chemistry of ascorbic acid – Wikipedia, accessed June 4, 2025, https://en.wikipedia.org/wiki/Chemistry_of_ascorbic_acid
9. Ascorbic acid – American Chemical Society, accessed June 4, 2025, https://www.acs.org/molecule-of-the-week/archive/a/ascorbic-acid.html
10. Scurvy at The Saint Croix Settlement (U.S. National Park Service), accessed June 4, 2025, https://www.nps.gov/articles/000/scurvy-at-saint-croix.htm
11. Treatments Of Scurvy – Consensus Academic Search Engine, accessed June 4, 2025, https://consensus.app/questions/treatments-of-scurvy/
12. Controlled Experiments – Math | USU – Utah State University, accessed June 4, 2025, https://math.usu.edu/schneit/StatsStuff/Data/data2.html
13. James Lind: Pioneer of the First Clinical Trial – Vitalief, accessed June 4, 2025, https://vitalief.com/blog/james-lind-pioneer-of-the-first-clinical-trial/
14. History of scurvy, why does it matter today? | Saul Marcus, ND – Naturopathic Doctor, accessed June 4, 2025, https://saulmarcusnd.com/2021/01/15/history-of-scurvy-why-does-it-matter-today/
15. Vitamin C: new role of the old vitamin in the cardiovascular system? – PMC, accessed June 4, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC1615860/
16. FOOD FORTIFICATION – Global Agribusiness – International Finance Corporation, accessed June 4, 2025, https://www.ifc.org/content/dam/ifc/doc/2023/foodfortificationleafletscombined-ifc-2023.pdf
17. About Food Fortification: Definition, Benefits | Kellogg’s MENAT, accessed June 4, 2025, https://www.kelloggs.com/me/en/health-and-nutrition/food-fortification-definition-benefits.html
18. Scurvy: Symptoms, Causes & Treatment – Cleveland Clinic, accessed June 4, 2025, https://my.clevelandclinic.org/health/diseases/24318-scurvy
19. Vitamin C – The Nutrition Source, accessed June 4, 2025, https://nutritionsource.hsph.harvard.edu/vitamin-c/
20. Intravenous High-Dose Vitamin C in Cancer Therapy – NCI, accessed June 4, 2025, https://www.cancer.gov/research/key-initiatives/ras/news-events/dialogue-blog/2020/yun-cantley-vitamin-c
21. Scurvy – Wikipedia, accessed June 4, 2025, https://en.wikipedia.org/wiki/Scurvy
22. Scurvy: past, present and future – PubMed, accessed June 4, 2025, https://pubmed.ncbi.nlm.nih.gov/21402244/
23. Can Vitamin C cure the common cold? Hold on | Office for Science …, accessed June 4, 2025, https://www.mcgill.ca/oss/article/health-and-nutrition-history/can-vitamin-c-cure-common-cold-hold
24. Vitamin C: Evolution, Prehistory, and History – Science and Education Publishing, accessed June 4, 2025, https://pubs.sciepub.com/jfnr/12/5/4/index.html
25. Scurvy: Rediscovering a Forgotten Disease – MDPI, accessed June 4, 2025, https://www.mdpi.com/2079-9721/11/2/78
26. Vitamin C: From Self-Sufficiency to Dietary Dependence in the …, accessed June 4, 2025, https://www.mdpi.com/2075-1729/15/2/238
27. Vitamin C and Skin Health | Linus Pauling Institute | Oregon State University, accessed June 4, 2025, https://lpi.oregonstate.edu/mic/health-disease/skin-health/vitamin-C
28. Vitamin C Physiological Function – News-Medical, accessed June 4, 2025, https://www.news-medical.net/health/Vitamin-C-Physiological-Function.aspx
29. Vitamin C: A Comprehensive Review of Its Role in Health, Disease Prevention, and Therapeutic Potential – MDPI, accessed June 4, 2025, https://www.mdpi.com/1420-3049/30/3/748
30. Exploring the Role of Vitamin C in Gastrointestinal Function and Disorders – Practical Gastro, accessed June 4, 2025, https://practicalgastro.com/2025/03/14/exploring-the-role-of-vitamin-c-in-gastrointestinal-function-and-disorders/
31. Linus Pauling And Vitamin C – Consensus Academic Search Engine, accessed June 4, 2025, https://consensus.app/questions/linus-pauling-and-vitamin-c/
32. Vitamin C – Health Professional Fact Sheet, accessed June 4, 2025, https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/
33. Too much vitamin C: Is it harmful? – Mayo Clinic, accessed June 4, 2025, https://www.mayoclinic.org/healthy-lifestyle/nutrition-and-healthy-eating/expert-answers/vitamin-c/faq-20058030